Next-generation Cancer Immunotherapies

First-in-class non-coding RNAs medicines for obesity and metabolic diseases

Innovative medicines for central nervous system disorders

RNA-based therapies to induce cardiac regeneration

New drugs for incurable respiratory diseases

Drug discovery platform to unveil new class of small-molecule degraders

Development of innovative compounds that prevent metastasis

Developing new therapeutics to silence transcriptional factors of oncogenes

TCR-based therapies to treat ALK positive tumors

Reprogramming the solid tumor microenvironment to unlock the full potential of cancer immunotherapy